CIBAR1 and myasthenia gravis: Briefly, a genome-wide single nucleotide variant analysis followed by prioritization based on skeletal muscle gene expression (from GTExPortal) [8], identified putative modifier variants in FAM92A1 and PEF1, which were more frequent in OP-MG vs control MG genomes (p < 1 × 10–5) [6].